Limited partnership · Uccle · incorporated on 06/01/2022
| 2023 | 2022 | |||
|---|---|---|---|---|
| Revenue | — | 58,5 k € | ||
| Gross margin | 17,2 k € | -70.5% | 58,5 k € | |
| EBITDA | 16,9 k € | -71.0% | 58,1 k € | |
| Operating profit | 16,9 k € | -71.0% | 58,1 k € | |
| Profit/loss | 13,5 k € | -71.0% | 46,5 k € | |
| Equity | 60,0 k € | +29.0% | 46,5 k € | |
| Total assets | 359,7 k € | +519.1% | 58,1 k € | |
| Debts | 299,4 k € | +2476.1% | 11,6 k € | |
Company — Opening of bankruptcy.
Limited partnership profitable and well capitalised.
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Key indicators
ANS is a Limited partnership incorporated in 2022. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Uccle.